ALVEOLAR SOFT PART SARCOMA
Clinical trials for ALVEOLAR SOFT PART SARCOMA explained in plain language.
Never miss a new study
Get alerted when new ALVEOLAR SOFT PART SARCOMA trials appear
Sign up with your email to follow new studies for ALVEOLAR SOFT PART SARCOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New combo therapy aims to delay sarcoma progression
Disease control Recruiting nowThis study tests whether adding the immunotherapy drug pembrolizumab to a targeted chemotherapy infusion (ILI with melphalan and dactinomycin) can safely delay cancer growth in people with advanced sarcoma in an arm or leg. About 30 participants aged 12 and older will receive the…
Matched conditions: ALVEOLAR SOFT PART SARCOMA
Phase: PHASE2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated May 26, 2026 04:50 UTC
-
New stem cell approach aims to boost immune attack on tough childhood cancers
Disease control Recruiting nowThis study tests a stem cell transplant that removes certain immune cells (alpha/beta T cells and CD19+ B cells) and adds a drug called zoledronic acid to help the donor cells fight solid tumors that have come back or not responded to treatment. It includes children and young adu…
Matched conditions: ALVEOLAR SOFT PART SARCOMA
Phase: PHASE1, PHASE2 • Sponsor: University of Florida • Aim: Disease control
Last updated May 26, 2026 04:38 UTC
-
Hope for rare sarcoma: new pill shows promise in Late-Stage trial
Disease control Recruiting nowThis study tests a daily pill called AL3818 (anlotinib) for people with a rare cancer called alveolar soft part sarcoma (ASPS) that has spread. The goal is to see if the drug can shrink tumors or slow the cancer. About 325 adults with ASPS are being enrolled. Participants take th…
Matched conditions: ALVEOLAR SOFT PART SARCOMA
Phase: PHASE3 • Sponsor: Advenchen Laboratories, LLC • Aim: Disease control
Last updated May 26, 2026 04:34 UTC
-
New drug combo shows promise for rare sarcoma in early trial
Disease control Recruiting nowThis study tests a combination of two drugs (benmelstobart and anlotinib) in people aged 14 and older with advanced or inoperable alveolar soft part sarcoma, a rare soft tissue cancer. The main goal is to see if the treatment shrinks tumors. About 33 participants will receive the…
Matched conditions: ALVEOLAR SOFT PART SARCOMA
Phase: PHASE2 • Sponsor: Chia Tai Tianqing Pharmaceutical Group Co., Ltd. • Aim: Disease control
Last updated May 18, 2026 12:09 UTC
-
500 rare sarcoma patients enrolled to unlock immune secrets
Knowledge-focused Recruiting nowThis study aims to learn more about the immune system's role in rare types of sarcoma, a group of cancers. Researchers will collect medical information and tissue samples from 500 patients with these rare sarcomas. The goal is to find patterns that could lead to better treatments…
Matched conditions: ALVEOLAR SOFT PART SARCOMA
Phase: NA • Sponsor: Institut Claudius Regaud • Aim: Knowledge-focused
Last updated May 18, 2026 12:03 UTC